A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Eosinophilic esophagitis in the era of biologics. | LitMetric

Eosinophilic esophagitis in the era of biologics.

Expert Rev Gastroenterol Hepatol

Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.

Published: June 2024

AI Article Synopsis

  • - Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder of the esophagus that causes symptoms like difficulty swallowing and food getting stuck, and it could lead to more serious complications like strictures.
  • - The review discusses EoE's symptoms, progression, and current treatment strategies, with a focus on trials for biologic therapies aimed at managing inflammation.
  • - Dupilumab is the first biologic approved for EoE, and while it shows promise, ongoing studies are needed to understand its long-term effects, with other new drugs also being tested that may change treatment approaches.

Article Abstract

Introduction: Eosinophilic esophagitis (EoE) is a chronic inflammatory, disabling disorder characterized by prominent eosinophilic inflammation of the esophagus, leading to troublesome symptoms including dysphagia and food impaction. The natural history of EoE is poorly known, but it may lead to esophageal strictures. The therapeutic armamentarium is expected to grow in the near future, especially due to the availability of novel biological therapies targeting crucial inflammatory pathways of EoE.

Areas Covered: In this review, we discuss the main clinical features and natural history of EoE, focusing on the current therapeutic strategies, as well as past and current trials investigating biologics for its treatment.

Expert Opinion: Dupilumab has been the first approved biologic drug for the treatment of EoE; long-term studies assessing how it could change the natural history of EoE are awaited. Novel biological drugs or other molecules are currently under study and could change the current treatment algorithms in the near future. Proper drug positioning and long term 'exit strategies' are yet to be defined.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474124.2024.2374471DOI Listing

Publication Analysis

Top Keywords

natural history
12
history eoe
12
eosinophilic esophagitis
8
novel biological
8
eoe
5
esophagitis era
4
era biologics
4
biologics introduction
4
introduction eosinophilic
4
esophagitis eoe
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!